Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1176/appi.neuropsych.12030070 | DOI Listing |
J Neuropsychiatry Clin Neurosci
January 2014
Health Technol Assess
August 2011
Division of Primary Care, University of Nottingham, Nottingham, UK.
Objectives: The aim of this study was to establish the relative safety and balance of risks for antidepressant treatment in older people. The study objectives were to (1) determine relative and absolute risks of predefined adverse events in older people with depression, comparing classes of antidepressant drugs [tricyclic and related antidepressants (TCAs), selective serotonin reuptake inhibitors (SSRIs), monoamine oxidase inhibitors (MAOIs) and other antidepressants] and commonly prescribed individual drugs with non-use of antidepressant drugs; (2) directly compare the risk of adverse events for SSRIs with TCAs; (3) determine associations with dose and duration of antidepressant medication; (4) describe patterns of antidepressant use in older people with depression; and (5) estimate costs of antidepressant medication and primary care visits.
Design: A cohort study of patients aged 65 years and over diagnosed with depression.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!